Henriquez, Joseph E <br/><br/>
Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists.  [electronic resource] 

 -  Toxicology and applied pharmacology  04 2019 
 - 82-89 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1096-0333 
<br/><br/><label>Standard No.: </label>10.1016/j.taap.2019.02.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents--pharmacology<br/>Cannabinoid Receptor Agonists--pharmacology<br/>Cannabinoids--pharmacology<br/>Cells, Cultured<br/>Dendritic Cells--drug effects<br/>Humans<br/>Indoles--pharmacology<br/>Interferon-gamma--metabolism<br/>Oligodeoxyribonucleotides--pharmacology<br/>Phosphorylation<br/>Receptor, Cannabinoid, CB2--agonists<br/>Signal Transduction<br/>Tumor Necrosis Factor-alpha--metabolism